β€’
Mar 29

Plexus Q2 2025 Earnings Report

Plexus reported solid financial performance in Q2 2025, exceeding non-GAAP EPS guidance and delivering strong revenue and cash flow.

Key Takeaways

Plexus delivered $980 million in revenue for Q2 2025, with GAAP EPS of $1.41 and non-GAAP EPS of $1.66. Net income reached $39.1 million, and the company generated positive free cash flow while securing significant new program wins.

Revenue reached $980 million, in line with guidance.

Non-GAAP EPS of $1.66 exceeded guidance, driven by strong operational efficiency.

Free cash flow of $16.5 million supported $12.2 million in share repurchases.

42 new program wins contributed $205 million in annualized revenue.

Total Revenue
$980M
Previous year: $967M
+1.3%
EPS
$1.66
Previous year: $0.94
+76.6%
ROIC
13.7%
Economic Return
4.8%
Cash Cycle Days
68
Gross Profit
$97.8M
Previous year: $88.1M
+11.0%
Cash and Equivalents
$311M
Previous year: $265M
+17.2%
Free Cash Flow
$16.5M
Previous year: $64.9M
-74.6%
Total Assets
$3.09B
Previous year: $3.28B
-5.8%

Plexus

Plexus

Plexus Revenue by Segment

Plexus Revenue by Geographic Location

Forward Guidance

Plexus projects revenue of $1.00 to $1.04 billion and non-GAAP EPS of $1.65 to $1.80 for Q3 2025.

Positive Outlook

  • Revenue expected to increase to $1.00–1.04 billion
  • Non-GAAP EPS guidance of $1.65 to $1.80
  • Operating margin guidance of 5.7% to 6.1%
  • Strong win momentum including largest healthcare services win
  • Positive cash flow performance expected to continue

Challenges Ahead

  • Ongoing tariff-related uncertainty
  • Conservative outlook for the remainder of the year
  • Pressure on inventory levels and cost structures
  • Macroeconomic volatility impacting customer demand
  • Dependency on key sectors and top 10 customers

Revenue & Expenses

Visualization of income flow from segment revenue to net income